1. Agah R, Mazumder A (1989) The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplant setting. J Clin Immunol 9: 223
2. Agah R, Malloy B, Kerner M, Mazumder A (1989) Generation and characterization of IL-2 activated bone marrow cells as a potent graft vs leukemia effector in transplantation. J Immunol 143: 3093
3. Agah R, Malloy B, Kerner M, Girgis E, Bean P, Twoney P, Mazumder A (1989) Potent graft antitumor effect in natural killerresistant disseminated tumors by transplantation of interleukin-2 activated syngeneic bone marrow in mice. Cancer Res 49: 5959
4. Antin JH, Ault KA, Rappeport JM, Smith BR (1987) Blymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes. J Clin Invest 80: 325
5. Atkinson K (1990) Reconstitution of the hemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 5: 2091